| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
DOK1 |
DOK1: Docking protein 1 |
9.0 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
9.0 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
9.0 |
Evidence |
|
| U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
8.98 |
Evidence |
O
|
| CARS |
CARS: Cysteinyl-tRNA synthetase, cytoplasmic |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
8.98 |
Evidence |
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
SNRPD1 |
SNRPD1: Small nuclear ribonucleoprotein Sm D1 |
8.98 |
Evidence |
|
| STX1B2 |
STX1B, STX1B1, STX1B2: Syntaxin-1B |
VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
8.967 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB6C |
RAB6C, WTH3: Ras-related protein Rab-6C |
8.967 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB10 |
RAB10: Ras-related protein Rab-10 |
8.967 |
Evidence |
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB5B |
RAB5B: Ras-related protein Rab-5B |
8.967 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
O
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
8.962 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
IL15RA |
IL15RA: Interleukin-15 receptor alpha chain precursor |
8.962 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
8.962 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
8.962 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
IL15RA |
IL15RA: Interleukin-15 receptor alpha chain precursor |
8.962 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
8.962 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
8.962 |
Evidence |
|
| CEACAM1 |
CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr |
CRKL |
CRKL: Crk-like protein |
8.962 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
GAB2 |
IPI00186990 |
8.962 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
8.962 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRLR |
PRLR: Prolactin receptor precursor |
8.962 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CEACAM1 |
CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr |
8.962 |
Evidence |
|
| TP73 |
TP73, P73: Tumor protein p73 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
8.962 |
Evidence |
|